Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis

Neuroscience Letters

Volumn 534, Issue 1, 2013, Pages 85-89

  Takano, Masaoki ^a   Yamashita, Takuya ^b,c   Nagano, Kazuya ^c   Otani, Mieko ^a   Maekura, Kouji ^a   Kamada, Haruhiko ^c   Tsunoda, Shin ichi ^c   Tsutsumi, Yasuo ^b,c   Tomiyama, Takami ^e,f   Mori, Hiroshi ^e,f   Matsuura, Kenji ^d   Matsuyama, Shogo ^d  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d HIMEJI DOKKYO UNIVERSITY   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

2D DIGE; Alzheimer's disease; Amyloid oligomers; Hippocampus; Proteome

Indexed keywords

ALPHA ENOLASE; ALPHA INTERNEXIN; BETA ACTIN; BETA TUBULIN; CASEIN KINASE I; CHAPERONE; CHAPERONIN 60; CLATHRIN LIGHT CHAIN; DYNAMIN I; HEAT SHOCK COGNATE PROTEIN 71; HEAT SHOCK PROTEIN; NEURON SPECIFIC ENOLASE; PHOSPHOPROTEIN; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOSKELETON; ENERGY RESOURCE; FLUORESCENCE; HIPPOCAMPUS; LIQUID CHROMATOGRAPHY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHROMATOGRAPHY, LIQUID; FLUORESCENCE; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; PROTEOME; TANDEM MASS SPECTROMETRY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84873055610     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.11.010     Document Type: Article

References (25)

1. Andersson U., Antonicka H., Houstek J., Cannon B. A novel principle for conferring selectivity to poly(A)-binding proteins: interdependence of two ATP synthase beta-subunit mRNA-binding proteins. Biochemical Journal 2000, 346(Pt 1):33-39.
2. Chien C.L., Liem R.K. Characterization of the mouse gene encoding the neuronal intermediate filament protein alpha-internexin. Gene 1994, 149:289-292.
3. Ferreira A., Caceres A., Kosik K.S. Intraneuronal compartments of the amyloid precursor protein. Journal of Neuroscience 1993, 13:3112-3123.
4. Fulga T.A., Elson-Schwab I., Khurana V., Steinhilb M.L., Spires T.L., Hyman B.T., Feany M.B. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nature Cell Biology 2007, 9:139-148.
5. Gorg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000, 21:1037-1053.
6. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
7. Hirst J., Robinson M.S. Clathrin and adaptors. Biochimica et Biophysica Acta 1998, 1404:173-193.
8. Hunt C.R., Parsian A.J., Goswami P.C., Kozak C.A. Characterization and expression of the mouse Hsc70 gene. Biochimica et Biophysica Acta 1999, 1444:315-325.
9. Ikawa S., Weinberg R.A. An interaction between p21ras and heat shock protein hsp60, a chaperonin. Proceedings of the National Academy of Sciences 1992, 89:2012-2016.
10. Johnson J.L., Halas A., Flom G. Nucleotide-dependent interaction of Saccharomyces cerevisiae Hsp90 with the cochaperone proteins Sti1, Cpr6, and Sba1. Molecular and Cellular Biology 2007, 27:768-776.
11. Kaghad M., Dumont X., Chalon P., Lelias J.M., Lamande N., Lucas M., Lazar M., Caput D. Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain. Nucleic Acids Research 1990, 18:3638.
12. Kelly B.L., Vassar R., Ferreira A. Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. Journal of Biological Chemistry 2005, 280:31746-31753.
13. Klein W.L., Krafft G.A., Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends in Neurosciences 2001, 24:219-224.
14. Kuhn T.B., Meberg P.J., Brown M.D., Bernstein B.W., Minamide L.S., Jensen J.R., Okada K., Soda E.A., Bamburg J.R. Regulating actin dynamics in neuronal growth cones by ADF/cofilin and rho family GTPases. Journal of Neurobiology 2000, 44:126-144.
15. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annual Review of Neuroscience 2001, 24:1121-1159.
16. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
17. Modregger J., Ritter B., Witter B., Paulsson M., Plomann M. All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. Journal of Cell Science 2000, 113(Pt 24):4511-4521.
18. Nixon R.A., Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends in Neurosciences 1991, 14:501-506.
19. Robinson R.A., Lange M.B., Sultana R., Galvan V., Fombonne J., Gorostiza O., Zhang J., Warrier G., Cai J., Pierce W.M., Bredesen D.E., Butterfield D.A. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-beta peptide of amyloid precursor protein. Neuroscience 2011, 177:207-222.
20. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
21. Shin S.J., Lee S.E., Boo J.H., Kim M., Yoon Y.D., Kim S.I., Mook-Jung I. Profiling proteins related to amyloid deposited brain of Tg2576 mice. Proteomics 2004, 4:3359-3368.
22. Sultana R., Boyd-Kimball D., Cai J., Pierce W.M., Klein J.B., Merchant M., Butterfield D.A. Proteomics analysis of the Alzheimer's disease hippocampal proteome. Journal of Alzheimer's Disease 2007, 11:153-164.
23. Takano M., Maekura K., Otani M., Sano K., Nakamura-Hirota T., Tokuyama S., Min K.S., Tomiyama T., Mori H., Matsuyama S. Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid beta oligomers. Neurochemistry International 2012, 61:347-355.
24. Takano M., Otani M., Sakai A., Kadoyama K., Matsuyama S., Matsumoto A., Takenokuchi M., Sumida M., Taniguchi T. Use of a phosphosensor dye in proteomic analysis of human mutant tau transgenic mice. Neuroreport 2009, 20:1648-1653.
25. Tomiyama T., Matsuyama S., Iso H., Umeda T., Takuma H., Ohnishi K., Ishibashi K., Teraoka R., Sakama N., Yamashita T., Nishitsuji K., Ito K., Shimada H., Lambert M.P., Klein W.L., Mori H. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. Journal of Neuroscience 2010, 30:4845-4856.